Researchers from the University of Oslo have developed an innovative tool that promises to improve our understanding of heritable human traits and diseases.
Promising Debut for CRISPR Gene Editing Therapy for LDL Lowering
PHILADELPHIA — A DNA base editing therapy, intended for lifelong lowering of LDL cholesterol, passed initial tests in people with severe, advanced atherosclerotic cardiovascular disease